PTD4 Peptide Increases Neural Viability in an In Vitro Model of Acute Ischemic Stroke

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Ischemic stroke involves disrupted cerebral blood flow, leading to brain tissue ischemia and hypoxia.
• Developing effective treatments for acute ischemic stroke remains a significant challenge.
• Cell-penetrating peptides (CPPs) show potential for therapeutic delivery across cell membranes.

Purpose of the Study:

• To evaluate the neuroprotective potential of two cell-penetrating peptides, Tat(49-57)-NH2 and PTD4, in an in vitro model of acute ischemic stroke.
• To elucidate the relationship between peptide structure, membrane interaction, and neuroprotective activity.

Main Methods:

• Optimization of a multifactorial in vitro model of acute ischemic stroke using rat primary neural cultures.
• Assessment of peptide neurotoxicity and pro-survival activity using various biochemical assays.
• Structural analysis using circular dichroism spectroscopy and molecular dynamics simulations.

Main Results:

• PTD4 exhibited more pronounced pro-survival activity compared to Tat(49-57)-NH2 in the stroke model.
• Peptide neurotoxicity was not observed below 50 μm concentration.
• PTD4's helical structure in membrane-mimicking environments correlated with enhanced cell membrane permeability and neuroprotection, independent of arginine content.

Conclusions:

• The study identified PTD4 as a promising candidate for acute ischemic stroke treatment.
• Peptide conformational changes in response to membrane-like environments are crucial for its therapeutic efficacy.
• PTD4's structure-activity relationship suggests its potential as a leader sequence for novel neuroprotective drugs.